Source:http://linkedlifedata.com/resource/pubmed/id/18575715
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-6-25
|
pubmed:abstractText |
Gallbladder carcinoma (GC) is a relatively uncommon malignancy and is often caused by diagnostic difficulties in distinguishing the extension of carcinoma in situ (CIS) from invasive carcinoma along Rokitansky-Aschoff sinuses (RAS). The laminin-5, a heterotrimer, is composed of alpha-3, beta-3 and gamma-2 chains. The gamma-2 chain is expressed in various invasive carcinoma cells. There are numerous reports that have described that laminin-5-gamma-2 is associated with tissue invasion in many organs. However, few studies are found in gallbladder carcinoma. To clarify the relationship between laminin-5-gamma-2 chain (LN-5) expression and the development of GCs, we performed an immunohistochemical study of 93 GCs. Cases were classified into three groups: CIS with/without the extension along RAS (Group A; n=17), carcinoma invading mucosa or muscular layer (Group B; n=5) and carcinoma invading beyond perimuscular connective tissue (Group C; n=71). The immunohistochemical intracytoplasmic expression was detected in the invasive fronts of the tumor. In the invasive components of Group B and C, LN-5 was expressed in 100 and 97% of cases, respectively, whereas in the CIS lesions of GCs, expression was not observed in Group A. LN-5 expression in the GCs tended to increase as tumors developed, which may be an indicator of the potential invasiveness of the tumor. Our results indicate that, in GCs, a strong intracytoplasmic expression of LN-5 was identified in the cancer cells whether in situ they extend along RAS or invading stroma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1021-335X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
33-9
|
pubmed:meshHeading |
pubmed-meshheading:18575715-Aged,
pubmed-meshheading:18575715-Aged, 80 and over,
pubmed-meshheading:18575715-Carcinoma in Situ,
pubmed-meshheading:18575715-Cell Adhesion Molecules,
pubmed-meshheading:18575715-Female,
pubmed-meshheading:18575715-Gallbladder Neoplasms,
pubmed-meshheading:18575715-Humans,
pubmed-meshheading:18575715-Male,
pubmed-meshheading:18575715-Middle Aged,
pubmed-meshheading:18575715-Neoplasm Invasiveness,
pubmed-meshheading:18575715-Tumor Markers, Biological
|
pubmed:year |
2008
|
pubmed:articleTitle |
Laminin-5 (gamma2 chain) is a marker of invading cancer cells in human gallbladder carcinoma: special emphasis on extension of carcinoma in situ along Rokitansky-Aschoff sinuses.
|
pubmed:affiliation |
Kyushu Cancer Center, Fukuoka 811-1395, Japan. eguchi.t@hamanomachi.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|